Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NN-Labs Receives $2 million in SBIR Contracts

NN-Labs Receives $2 million in SBIR Contracts

Fayetteville, AR | Posted on October 17, 2006

­NN-Labs, LLC (Nanomaterials and Nanofabrication Laboratories), an Arkansas based nanotechnology firm, was recently awarded three Small Business Innovation Research (SBIR) contracts. The awards consist of two Phase II contracts, from the National Institutes of Health (NIH) and the National Science Foundation (NSF), and one Phase I contract from NIH; all three contracts total $1.8 million. Work on these new projects is already underway.

The funds will aid in NN-Labs’ ability to extend its strength in nanocrystals into end products in the biomedical field. Currently, cadmium containing semiconductor nanocrystals constitute all of the company’s standardized product lines for semiconductor nanocrystals, also known as quantum dots. While non-cadmium containing nanomaterials, such as gold nanoparticles and iron oxide (Fe3O4) magnetic Nanoparticles, are available through custom orders, the product lines are not yet complete or standardized.

The NIH Phase II, entitled Kits for Converting Nanocrystals to Standard Bio-Medical Reagents, Second Generation Nanocrystal Bio-Medical Labels follows the success of the Phase I that focused on the development of bio-medical labels based on the first generation of semiconductor nanocrystals, CdSe quantum dots. NN-Labs will develop the second generation of quantum dots, which are doped zinc containing semiconductor nanocrystals (d-dots). D-dots will ultimately remove heavy metal cadmium from the current workhorse—cadmium selenide related nanocrystals—of quantum dots. In addition, d-dots are also more durable and have better optical properties when high density emitters are needed. It is expected that these new fluorescence labels will make early diagnosis of various diseases and pathogens more practical and less expensive.

Commercial Scale Production of High Quality and Affordable Fe3O4 Nanocrystals for Nano-Biomedicine is the title of the NSF Phase II contract that will expand upon the product line developed in the Phase I contract. The biomedical applications for these Fe3O4 magnetic nanocrystals cover many aspects of the biomedical field, ranging from diagnostics, detection, therapy, separation, and pollution control, etc, which is at least a multi-billion-dollar market. Yet another variety of nanocrystal is to be developed with funding from the NIH Phase I contract, entitled High Yield and Inexpensive Production of High Quality Gold Nanocrystals as Bio-Labels. Similar to the other contracts, the end goal is to enhance already existing biomedical techniques as well as open the door to novel applications in the biomedical field. NN-Labs strives to complete this Phase I as successfully as we have for other Phase I awards, which will help us to secure the corresponding Phase II award from NIH with additional funding of $750K for two years.

NN-Labs has been business active for about four years, since July of 2002. The company has received 15 SBIR contracts (about $5m in total) that have partially funded the development of four standardized product lines, with several other product lines that are still under development and in the trial sales stage. The company maintains affiliations with the University of Arkansas and the Arkansas Science and Technology Authority (ASTA). NN-Labs is also a member of the Genesis Technology Incubator. Additional information about NN-Labs can be found on the company’s website, www.nn-labs.com, or by contacting Leah Sheridan at 479-575-2723 or lmbulla@nn-labs.com.

####

Contact:
Leah Sheridan
479-575-2723
lmbulla@nn-labs.com

Copyright © NN-Labs, LLC

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Arrowhead Issues Open Letter to Shareholders October 9th, 2014

PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Harris & Harris Group Letter to Shareholders on Website August 19th, 2014

Nanomedicine

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

Tuning light to kill deep cancer tumors: Nanoparticles developed at UMass Medical School advance potential clinical application for photodynamic therapy October 15th, 2014

Materials/Metamaterials

Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014

Nanotechnology Improves Quality of Anti-Corrosive Coatings October 17th, 2014

Graphenea opens US branch October 16th, 2014

3DXNano™ ESD Carbon Nanotube 3D Printing Filament - optimized for demanding 3D printing applications in the semi-con and electronics industry October 16th, 2014

Announcements

Imaging electric charge propagating along microbial nanowires October 20th, 2014

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Physicists build reversible laser tractor beam October 20th, 2014

Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE